Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

From Chemistry to the Clinic, Part 2: Pharmacokinetics in Cancer Drug Discovery and Development (Educational Session)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Pharmacokinetics in drug discovery
Michael Michaelides, Ph.D.
Abbott Laboratories, Abbott Park, IL
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Pharmacokinetic and pharmacodynamic considerations in translational development
Andrew P. Krivoshik, M.D., Ph.D.
Abbott Laboratories, Abbott Park, IL
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Pharmacokinetics in the clinical development of new anticancer agents: Where the rubber hits the road
Anthony W. Tolcher, M.D.
South Texas Accelerated Research Therapeutics, San Antonio, TX
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Regulatory perspective of the role of pharmacokinetics in drug discovery and development
Dr. Julie Bullock
Food and Drug Administration, Silver Spring, MD
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4